Journal: Chinese Medicine
Article Title: Electroacupuncture exerts antipruritic and anti-inflammatory effects on atopic dermatitis by activating CB2 receptor
doi: 10.1186/s13020-025-01102-4
Figure Lengend Snippet: Schematic diagram of this study's findings on the impact of EA on AD Mice. This schematic diagram presents the pathophysiological alterations in AD and the therapeutic interventions of EA treatment. Initially, upon the induction of AD, there is an escalation in the number of mast cells and CD4 + T cells within the skin lesions, along with upregulation of cytokines IL4, IL13, and IL31, and their receptors IL4R and IL31R in the cervical DRG. These changes are linked to the exacerbation of chronic itching and skin inflammation. Despite an upregulation of the CB2R, the endogenous levels are not adequate to effectively inhibit ERK phosphorylation, a key driver of inflammatory processes (left side). In contrast, EA treatment, applied via specific acupoints corresponding to the affected dermatome, initiates a cascade of anti-inflammatory effects. EA stimulates axon reflexes that enhance the synthesis of endocannabinoids and reduce their degradation in the lesional skin tissue. This results in elevated levels of the primary endocannabinoids such as AEA and 2-AG, which in turn upregulate the expression of CB2R. Stimulation of CB2R by endocannabinoids leads to a significant reduction in ERK hyperphosphorylation, an essential process in curbing inflammatory response. As a result, EA treatment diminishes the number of mast cells and CD4 + T cells in lesional skin, reduces the expression of pro-inflammatory cytokines IL4, IL13, and IL31, and decreases the expression of IL4R and IL31R in the cervical DRG. Collectively, these effects contribute to the alleviation of itching and the inhibition of inflammation development (right side)
Article Snippet: Adult male C57BL/6 J mice were obtained from Beijing Vital River Laboratory Animal Technology and male CB2 receptor knockout (CB2R −/− ) mice on C57BL/6 background aged 6–8 weeks from Jackson Laboratories (Strain #:005786).
Techniques: Phospho-proteomics, Expressing, Inhibition